These results suggest the involvement of TNF-α/NF-κB pathways in the functionality of HL EV, and this is one of the most relevant tumor drivers involved in the pathobiology of Hodgkin’s disease (3, 41). The gene discussed is NFKB1; the disease is neoplasm.